Faculty profile

Francois Lamontagne

ResearcherMédecine interneUniversité de Sherbrooke

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses may be missing. Find their university profile.

Francois Lamontagne

Researcher

Médecine interne

Health Sciences

Université de Sherbrooke

Sherbrooke, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
47 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 6 research grants (6 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

115

Publications

7,286

Citations

h-index

340

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Randomized Controlled Trial Supportive Care Vasopressors Usual Care Vasopressor Therapy Platelet Transfusion Cardiovascular Critical Care

Latest papers

Association Between Protocolized Magnesium Supplementation and Atrial Fibrillation or Flutter in Critically Ill Patients: A Multicenter Retrospective Cohort Study.
Critical care medicine · 2026
The Lancet Commission on Sepsis: transforming sepsis care and outcomes.
Lancet (London, England) · 2026
Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.
Journal of thrombosis and haemostasis : JTH · 2026

All 115 publications

Latest funding

OVATION-CEPEC: Optimal VAsopressor titraTION within the Canadian Critical Care Comparative Effectiveness Platform(e) d'Évaluation Clinique Comparée en soins Critiques (CEPEC)
CIHR · 2025 · Nominated PI
$3,021,752
Advancing Consent Methods for Transplant Research
CIHR · 2024 · Co-investigator
$20,000
Platelet Transfusion Domain of the Canadian Critical Care Comparative Effectiveness Platform(e) d'Évaluation Clinique Comparée en soins Critiques - (CEPEC)
CIHR · 2024 · Nominated PI
$1,193,400

All 8 grants and awards

115 publications.

Association Between Protocolized Magnesium Supplementation and Atrial Fibrillation or Flutter in Critically Ill Patients: A Multicenter Retrospective Cohort Study.

Yarnell CJ, Angriman F, Beaubien E, Brown J, Bruce-Kemevor S, Burry L, Craig J, Donato-Woodger S, Fernando SM, Fowler R, Kattakkayam T, Lamontagne F, Prakash V, Sikaneta T, Sibley S, Soliman K, Tomlinson G, Bodley T

Critical care medicine2026

DOI: 10.1097/ccm.0000000000007062 PMID: 41612529

The Lancet Commission on Sepsis: transforming sepsis care and outcomes.

Shankar-Hari M, Ming D, Mendelson M, Rupali P, Adhikari NKJ, Ranzani O, Randolph A, Davenport E, van der Poll T, Moita LF, Beane A, Lamontagne F, Kwizera A, Holmes A, Diaz J

Lancet (London, England)2026

DOI: 10.1016/s0140-6736(26)00648-3 PMID: 42034118

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) Investigators, Bradbury CA, McVerry BJ, Lawler PR, Angus DC, Annane D, Arabi YM, Aryal D, Au C, Beane A, Berry SM, Berry LR, Best-Lane J, Bihari S, Bonten M, Brunkhorst F, Burrell A, Buxton M, Carrier M, Cecconi M, Cheng AC, Cove M, Derde LPG, Detry MA, Estcourt LJ, Fergusson DA, Fitzgerald M, Fowler RA, Goligher EC, Green C, Haniffa R, Harrison DA, Hays LMC, Higgins AM, Hills T, Horvat CM, Huang DT, Hunt BJ, Ichihara N, Jayakumar D, Keattch S, Kumar A, Laffan MA, Lamontagne F, Leeper CM, Lewis RJ, Lorenzi E, Lother SA, Marshall JC, McArthur CJ, McAuley DF, McGlothlin A, McGuinness SP, McQuilten ZK, Middeldorp S, Morpeth S, Mouncey PR, Murthy S, Neal MD, Nichol AD, Parke RL, Parker JC, Peters S, Reyes LF, Rowan K, Saito H, Santos M, Saunders CT, Schutgens REG, Seymour CW, Hari MS, Singh V, Stanworth SJ, Turgeon AF, Turner AM, van de Veerdonk FL, Gordon AC, Webb SA, Zarychanski R

Journal of thrombosis and haemostasis : JTH2026

DOI: 10.1016/j.jtha.2026.03.006 PMID: 41895526

Mass cytometry reveals complex neutrophil heterogeneity in patients with severe sepsis.

Lima PDA, Yu C, Hunt M, Lamontagne F, Adhikari NKJ, Marshall JC, Hindmarch CCT, Maslove DM

Intensive care medicine experimental2026

DOI: 10.1186/s40635-026-00924-2 PMID: 42274989

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia

Lee TC, Barina LA, Walls G, Goodman AL, Yahav D, Cheng MP, Bonten M, Bowen AC, Boyles T, Daneman N

New England Journal of Medicine202613 citations

DOI: 10.1056/nejmoa2506905

Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections

Ramendra R, Wright JK, Kain KC, Kim B, Mishra H, Zhong K, Aslanian P, Carignan A, Conly J, Detsky M

JAMA Network Open20262 citations

DOI: 10.1001/jamanetworkopen.2026.20973

Survey of Intensivist Coverage and Interprofessional Team Staffing in Canadian ICUs

Wunsch H, Manoharan V, Hill A, Garland A, Costa DK, Kho ME, Lamontagne F, Murthy S, Stelfox HT, Hancock J

Critical Care Medicine20261 citations

DOI: 10.1097/ccm.0000000000007188

Population Pharmacokinetics of Intravenous Vitamin C in Adults with Sepsis: A Sub-study of the LOVIT Trial

Kanji S, Hernández-Mitre MP, Blain H, Adhikari NKJ, Lamontagne F, Battista M-C, Ménard J, Sprague S, Masse M-H, Roberts JA

Clinical Pharmacokinetics20261 citations

DOI: 10.1007/s40262-026-01648-y

Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial

Armstrong E, Pinto R, Kulikova M, Yee NR, Rishu A, Muscedere J, Sibley S, Maslove DM, Boyd JG, Evans GA

Clinical Infectious Diseases2026

DOI: 10.1093/cid/ciag460

Pantoprazole Use in Invasively Ventilated Patients With Septic Shock: A Protocol and Statistical Analysis Plan

Kuriyama A, Heels‐Ansdell D, Fernando SM, Adhikari NKJ, Lamontagne F, Teja B, Lewis KA, Rochwerg B, Carayannopoulos KL, Vazquez‐Grande G

Acta Anaesthesiologica Scandinavica2026

DOI: 10.1111/aas.70267

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Randomized Controlled Trial Dear Professor Lamontagne, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Association Between Protocolized Magnesium Supplementation and Atrial Fibrillation or Flutter in Critically Ill Patients: A Multicenter Retrospective Cohort Study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "OVATION-CEPEC: Optimal VAsopressor titraTION within the Canadian Critical Care Comparative Effectiveness Platform(e) d'Évaluation Clinique Comparée en soins Critiques (CEPEC)" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Francois Lamontagne

Research

Latest papers

Latest funding

Association Between Protocolized Magnesium Supplementation and Atrial Fibrillation or Flutter in Critically Ill Patients: A Multicenter Retrospective Cohort Study.

The Lancet Commission on Sepsis: transforming sepsis care and outcomes.

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Mass cytometry reveals complex neutrophil heterogeneity in patients with severe sepsis.

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia

Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections

Survey of Intensivist Coverage and Interprofessional Team Staffing in Canadian ICUs

Population Pharmacokinetics of Intravenous Vitamin C in Adults with Sepsis: A Sub-study of the LOVIT Trial

Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial

Pantoprazole Use in Invasively Ventilated Patients With Septic Shock: A Protocol and Statistical Analysis Plan

Frequent collaborators

Deborah Cook

Bram Rochwerg

Srinivas Murthy

Karen Burns

Jennifer Tsang

John Muscedere

Robert Fowler

Gordon Guyatt

Maureen Meade

Ryan Zarychanski

Erick Duan

Sangeeta Mehta

Peter Dodek

John Marshall

Diane Heels-Ansdell

Nick Daneman

Anand Kumar

Francois Lamontagne

Lauralyn McIntyre

Michelle Kho

Thomas Agoritsas

Gloria Vazquez-Grande

Patrick Archambault

François Lauzier

Rachel Couban

Peter Daley

Ian Ball

Timothy A Karachi

Emilie Belley-Cote

Kimia Honarmand

Romina Brignardello

Arnav Agarwal

Ryan Zarychanski

Ruxandra Pinto

Frederick D'Aragon

Allison McGeer

Margaret Herridge

Lehana Thabane

Shane English

Francois Lamontagne